TWO YEARS EXPERIENCE WITH SHIGELLOSIS IN A HOSPITAL AND SCHOOL FOR THE MENTALLY RETARDED.
D000900:Anti-Bacterial Agents; D002701:Chloramphenicol; D003140:Communicable Disease Control; D004405:Dysentery, Bacillary; D005664:Furazolidone; D007612:Kanamycin; D001523:Mental Disorders; D009017:Morbidity; D010118:Oxytetracycline; D010303:Paromomycin; D019989:Persons with Intellectual Disabilities; D011500:Protein Synthesis Inhibitors; D011802:Quinidine; D012762:Shigella dysenteriae; D013432:Sulfathiazoles; D013752:Tetracycline
D000900:Anti-Bacterial Agents; D011500:Protein Synthesis Inhibitors; D013432:Sulfathiazoles; D007612:Kanamycin; D005664:Furazolidone; D010303:Paromomycin; D002701:Chloramphenicol; D013752:Tetracycline; D011802:Quinidine; D010118:Oxytetracycline
CHLORAMPHENICOL; COMMUNICABLE DISEASE CONTROL; FURAZOLIDONE; KANAMYCIN; MENTAL DISORDERS; MORBIDITY; OXYTETRACYCLINE; PAROMOMYCIN; QUINIDINE; SHIGELLA DYSENTERIAE; SULFATHIAZOLES; TETRACYCLINE